\(
\def\WIPO{World Intellectual Property Organisation}
\)
Mexican Nano-Based Drug Delivery System Set to Boost Global Eye Health
2023
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS | |
Cite
Title
Mexican Nano-Based Drug Delivery System Set to Boost Global Eye Health
Item Type
Journal article
Description
1 article.
Summary
CRMQ (Centro de Retina Medica y Quirúrigca) in Mexico, which specializes in retinal diseases, has developed a groundbreaking nanotechnology platform for retinal drug delivery offering a more amenable and affordable treatment for some of the world’s most common eye diseases. CRMQ’s founder and General Director, Arturo Santos, and its Legal Counsel, Enrique Santos, recently met with WIPO Magazine to explain why this innovation is so important in the battle against irreversible blindness. CRMQ is one of the seven winners of the WIPO Global Awards 2023.
Series
Linked Resources
Translations
Published
Geneva, Switzerland : World Intellectual Property Organization, 2023.
Language
English
Record Appears in